CON: Intrahepatic cholangiocarcinoma should be a contraindication to liver transplantation.
Publication
, Journal Article
Wegermann, K; Henson, JB; King, LY
Published in: Clin Liver Dis (Hoboken)
February 2023
Duke Scholars
Published In
Clin Liver Dis (Hoboken)
DOI
ISSN
2046-2484
Publication Date
February 2023
Volume
21
Issue
2
Start / End Page
52 / 55
Location
United States
Citation
APA
Chicago
ICMJE
MLA
NLM
Wegermann, K., Henson, J. B., & King, L. Y. (2023). CON: Intrahepatic cholangiocarcinoma should be a contraindication to liver transplantation. Clin Liver Dis (Hoboken), 21(2), 52–55. https://doi.org/10.1097/CLD.0000000000000010
Wegermann, Kara, Jacqueline B. Henson, and Lindsay Y. King. “CON: Intrahepatic cholangiocarcinoma should be a contraindication to liver transplantation.” Clin Liver Dis (Hoboken) 21, no. 2 (February 2023): 52–55. https://doi.org/10.1097/CLD.0000000000000010.
Wegermann K, Henson JB, King LY. CON: Intrahepatic cholangiocarcinoma should be a contraindication to liver transplantation. Clin Liver Dis (Hoboken). 2023 Feb;21(2):52–5.
Wegermann, Kara, et al. “CON: Intrahepatic cholangiocarcinoma should be a contraindication to liver transplantation.” Clin Liver Dis (Hoboken), vol. 21, no. 2, Feb. 2023, pp. 52–55. Pubmed, doi:10.1097/CLD.0000000000000010.
Wegermann K, Henson JB, King LY. CON: Intrahepatic cholangiocarcinoma should be a contraindication to liver transplantation. Clin Liver Dis (Hoboken). 2023 Feb;21(2):52–55.
Published In
Clin Liver Dis (Hoboken)
DOI
ISSN
2046-2484
Publication Date
February 2023
Volume
21
Issue
2
Start / End Page
52 / 55
Location
United States